American International Group, Inc. Marker Therapeutics, Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$1.88 - $3.56 $33,371 - $63,193	-17,751 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$1.47 - $3.29 $67 - $151	46 Added 0.26%	17,751 $40,000
Q4 2020 Feb 12, 2021	BUY	$1.36 - $1.75 $78 - $101	58 Added 0.33%	17,705 $26,000
Q3 2020 Nov 04, 2020	SELL	$1.5 - $2.2 $601 - $882	-401 Reduced 2.22%	17,647 $27,000
Q2 2020 Aug 12, 2020	BUY	$1.69 - $2.79 $3,391 - $5,599	2,007 Added 12.51%	18,048 $37,000
Q1 2020 May 04, 2020	SELL	$1.59 - $3.35 $1,473 - $3,105	-927 Reduced 5.46%	16,041 $30,000
Q4 2019 Feb 05, 2020	SELL	$2.68 - $4.85 $385 - $698	-144 Reduced 0.84%	16,968 $49,000
Q3 2019 Nov 08, 2019	SELL	$4.1 - $9.0 $483 - $1,062	-118 Reduced 0.68%	17,112 $87,000
Q2 2019 Aug 13, 2019	BUY	$5.15 - $7.92 $88,734 - $136,461	17,230 New	17,230 $137,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $163M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.